Nasonex and Intelence drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasonex (mometasone furoate monohydrate) and Intelence (etravirine). Common drug interactions include palpitations among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Nasonex and Intelence. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

What is Intelence?

Intelence has active ingredients of etravirine. It is often used in hiv infection. eHealthMe is studying from 3,797 Intelence users. Check the latest studies of Intelence.



On Jul, 17, 2026

28 people who take Nasonex and Intelence together, and have interactions are studied.

Nasonex and Intelence drug interactions.

What are the common drug interactions of Nasonex and Intelence, by gender? *:

female:

  1. Palpitations (feelings or sensations that your heart is pounding or racing)
  2. Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Emotional distress
  7. Pain
  8. Chronic kidney disease
  9. Multiple fractures
  10. Osteonecrosis (death of bone)

male:

  1. Anxiety
  2. Emotional distress
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Osteoporosis (bones weak and more likely to break)
  6. Arthralgia (joint pain)
  7. Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
  8. Hepatitis a
  9. Hypertension (high blood pressure)
  10. Pyelonephritis (inflammation of kidney caused by bacteria)

What are the common drug interactions of Nasonex and Intelence, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Blood creatinine increased
  2. Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
  3. Depression
  4. Hepatitis a
  5. Hypertension (high blood pressure)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Pyelonephritis (inflammation of kidney caused by bacteria)
  8. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  9. Vitreous floaters (spots before the eyes)
  10. Rhinitis perennial (an inflammatory condition of the nose characterized by nasal obstruction, sneezing, itching)

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Emotional distress
  5. Pain
  6. Chronic kidney disease
  7. Tooth loss
  8. Confusional state
  9. Hyperhidrosis (abnormally increased sweating)
  10. Mydriasis (a dilation of the pupil)

50-59:

  1. Osteoporosis (bones weak and more likely to break)
  2. Asthenia (weakness)
  3. Bone loss
  4. Chronic kidney disease
  5. Depression
  6. Osteonecrosis (death of bone)
  7. Decreased activity
  8. Gait disturbance
  9. Multiple fractures
  10. Nephropathy (damage to or disease of a kidney)

60+:

  1. Depression
  2. Injury
  3. Neuropathy peripheral (surface nerve damage)

What are the existing conditions these people have? *

  1. Hiv Infection: 20 people, 71.43%
  2. Depression: 7 people, 25.00%
  3. High Blood Pressure: 5 people, 17.86%
  4. Skin Papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections): 3 people, 10.71%
  5. Kidney Infection (Pyelonephritis): 3 people, 10.71%
  6. Cytomegalovirus Chorioretinitis (infection of choroid and retina of the eye from virus): 3 people, 10.71%
  7. Cytomegalovirus Infection: 3 people, 10.71%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.71%
  9. Hepatitis A: 3 people, 10.71%
  10. Hypoaesthesia (reduced sense of touch or sensation): 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Nasonex and Intelence?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nasonex and Intelence:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Intelence:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Intelence and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate monohydrate and etravirine (the active ingredients of Nasonex and Intelence, respectively), and Nasonex and Intelence (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: